KERNAL
LIVE

Serial Number

97507484

Owner

Kernal Biologics

Attorney

Brandon P. Leahy

Filing Date

Jul 18, 2022

Add to watchlist:

No watchlists yet
View on USPTO

KERNAL Trademark

Serial Number: 97507484

KERNAL is a trademark filed by Kernal Biologics on July 18, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Kernal Biologics (3 trademarks)

700 Main St.
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

July 18, 2022

Registration Date

Not Registered

Published for Opposition

September 3, 2024

Goods & Services

Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Biochemicals for use in biotechnological manufacturing processes and product development, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids related to treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; nucleotides for scientific and research use; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; protein arrays and nucleotide arrays for scientific and medical research; nucleic acid for laboratory use; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; nucleic acid sequences for scientific purposes; polypeptide encoding nucleic acids for laboratory use

Medical, biological, and pharmaceutical preparations for treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; medical, biological and pharmaceutical preparations containing lipid nanoparticles for the prevention and treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; nucleic acid sequences and chemical reagents for medical and veterinary purposes

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 28, 2026 EXRA
SOU EXTENSION 3 GRANTED
Apr 28, 2026 EX3G
SOU EXTENSION 3 FILED
Apr 27, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 27, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 29, 2025 EXRA
SOU EXTENSION 2 GRANTED
Oct 28, 2025 EX2G
SOU EXTENSION 2 FILED
Oct 28, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 28, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 22, 2025 EXRA
SOU EXTENSION 1 GRANTED
Apr 21, 2025 EX1G
SOU EXTENSION 1 FILED
Apr 21, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 21, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 29, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 14, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 1, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 1, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 1, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 1, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 1, 2024 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 4, 2023 GNFN
FINAL REFUSAL E-MAILED
Dec 4, 2023 GNFR
FINAL REFUSAL WRITTEN
Dec 4, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 30, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 30, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 30, 2023 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 18, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 18, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 18, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 18, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 18, 2023 COAR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 21, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 21, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 3, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 3, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 3, 2023 CNRT
ASSIGNED TO EXAMINER
May 3, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2022 NWOS
NEW APPLICATION ENTERED
Jul 21, 2022 NWAP